|
|
||||
|
|
||||
|
||||
The managed care industry is at a crossroads. Belief in the ability of market forces alone to create an environment fostering quality health care at lower cost is eroding. Regulators across the country are confronted with a growing consumer backlash against managed care. As a result, states have passed managed care reform legislation at unprecedented rates. In doing so, states are confronted with a patchwork of federal intervention and preemption. We examine the stages of these recent state and federal developments and evaluate them in terms of the traditional objectives of a reasonably functioning health care system: quality care, access, and cost containment.
This article has been cited by other articles:
![]() |
K. Kronebusch, M. Schlesinger, and T. Thomas Managed Care Regulation in the States: The Impact on Physicians' Practices and Clinical Autonomy Journal of Health Politics Policy and Law, April 1, 2009; 34(2): 219 - 259. [Abstract] [PDF] |
||||
|
|